CTKB 6.32 (+2.1%)
US23285D1090Medical Devices & InstrumentsMedical Devices

Cytek Biosciences (CTKB) Stock Highlights

6.32 | +2.1%
2024-12-21 04:41:10
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells.

Statistics

Range Today
6.04 6.39
Volume Today 2.03M
Range 1 Year
4.66 9.87
Volume 1 Year 172.82M
Range 3 Year
3.8 18.05
Volume 3 Year 618.86M
Range 10 Year
3.8 28.7
Volume 10 Year 649.34M

Highlights

Market Capitalization 931.33M (small)
Floating Shares 112.57M
Current Price 6.32
Price To Earnings -88
Price To Revenue 3.24
Price To Book 2.39
Earnings Per Share -0.08
Payout Ratio 0%

Performance

Latest +2.1%
1 Month +3.78%
3 Months +19.92%
6 Months +12.86%
1 Year -33.54%
3 Years -63.32%
5 Years -68.56%
10 Years -68.56%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.